WTC
TAK icon

WhitTier Trust Company’s Takeda Pharmaceutical TAK Stock Holding History

WhitTier Trust Company’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-105
Closed -$1.62K – 1474
2025
Q2 		$1.62K Sell
105
-40
-28% -$591 ﹤0.01% 1332
2025
Q1 		$2.15K Sell
145
-1,232
-89% -$17.3K ﹤0.01% 1278
2024
Q4 		$18.2K Sell
1,377
-2,161
-61% -$29.7K ﹤0.01% 962
2024
Q3 		$50.3K Sell
3,538
-541
-13% -$7.67K ﹤0.01% 756
2024
Q2 		$52.8K Buy
4,079
+27
+0.7% +$357 ﹤0.01% 692
2024
Q1 		$56.3K Buy
4,052
+154
+4% +$2.24K ﹤0.01% 662
2023
Q4 		$55.6K Buy
3,898
+208
+6% +$2.95K ﹤0.01% 662
2023
Q3 		$57.1K Hold
3,690
– – ﹤0.01% 625
2023
Q2 		$58K Sell
3,690
-40
-1% -$655 ﹤0.01% 646
2023
Q1 		$61.4K Hold
3,730
– – ﹤0.01% 624
2022
Q4 		$58.2K Hold
3,730
– – ﹤0.01% 641
2022
Q3 		$48K Sell
3,730
-206
-5% -$2.86K ﹤0.01% 674
2022
Q2 		$55K Buy
3,936
+80
+2% +$1.14K ﹤0.01% 658
2022
Q1 		$55K Hold
3,856
– – ﹤0.01% 653
2021
Q4 		$53K Buy
3,856
+1,564
+68% +$21.9K ﹤0.01% 666
2021
Q3 		$38K Buy
2,292
+1,815
+381% +$30.5K ﹤0.01% 726
2021
Q2 		$8K Hold
477
– – ﹤0.01% 893
2021
Q1 		$9K Hold
477
– – ﹤0.01% 867
2020
Q4 		$9K Hold
477
– – ﹤0.01% 846
2020
Q3 		$9K Hold
477
– – ﹤0.01% 825
2020
Q2 		$9K Hold
477
– – ﹤0.01% 806
2020
Q1 		$7K Hold
477
– – ﹤0.01% 825
2019
Q4 		$9K Hold
477
– – ﹤0.01% 859
2019
Q3 		$8K Hold
477
– – ﹤0.01% 857
2019
Q2 		$8K Hold
477
– – ﹤0.01% 859
2019
Q1 		$10K Buy
+477
New +$9.6K ﹤0.01% 829

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

WhitTier Trust Company's TAK Position: Q3 2025 in Review

WhitTier Trust Company sold out of Takeda Pharmaceutical (TAK) in Q3 2025, closing a stake of 105 shares — an estimated $1.62K sold.

WhitTier Trust Company first reported a position in TAK in Q1 2019 and held it in 26 quarters. The position peaked at $61.4K in Q1 2023. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

  • WhitTier Trust Company reported no remaining Takeda Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 105 Takeda Pharmaceutical shares in Q3 2025, an estimated $1.62K.
  • WhitTier Trust Company first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 26 quarters.
  • WhitTier Trust Company's Takeda Pharmaceutical position peaked at $61.4K in Q1 2023.
  • 329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.